Synapse - The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy

The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy Research Letter

Authors:	Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; Epstein-Peterson, Z.; Menghrajani, K. N.; Glass, J. L.; Taylor, J.; Viny, A. D.; Giralt, S. S.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Levine, R. L.; Tallman, M. S.; Stein, E. M.
Title:	The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
Journal Title:	American Journal of Hematology
Volume:	96
Issue:	5
ISSN:	0361-8609
Publisher:	John Wiley & Sons, Inc.
Date Published:	2021-05-01
Start Page:	E171
End Page:	E175
Language:	English
DOI:	10.1002/ajh.26146
PUBMED:	33650111
PROVIDER:	scopus
PMCID:	PMC8335797
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102933035&doi=10.1002%2fajh.26146&partnerID=40&md5=9e7176dd686df79d97e4ef32c47752d7
Notes:	Letter -- Export Date: 3 May 2021 -- Source: Scopus